tradingkey.logo

Retractable Technologies Inc

RVP

0.740USD

-0.003-0.38%
Market hours ETQuotes delayed by 15 min
22.15MMarket Cap
LossP/E TTM

Retractable Technologies Inc

0.740

-0.003-0.38%
More Details of Retractable Technologies Inc Company
Retractable Technologies, Inc. is engaged in manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.
Company Info
Ticker SymbolRVP
Company nameRetractable Technologies Inc
IPO dateMay 04, 2001
CEOMr. Thomas J. Shaw
Number of employees221
Security typeOrdinary Share
Fiscal year-endMay 04
Address511 Lobo Lane
CityLITTLE ELM
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code75068-0009
Phone19722941010
Websitehttps://retractable.com/
Ticker SymbolRVP
IPO dateMay 04, 2001
CEOMr. Thomas J. Shaw
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas J. Shaw
Mr. Thomas J. Shaw
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
16.33M
+0.34%
Mr. Marco Laterza, CPA
Mr. Marco Laterza, CPA
Independent Director
Independent Director
85.00K
--
Mr. Darren E. Findley
Mr. Darren E. Findley
Independent Director
Independent Director
4.20K
--
Mr. John W. Fort, III
Mr. John W. Fort, III
Chief Financial Officer, Vice President, Treasurer, Director
Chief Financial Officer, Vice President, Treasurer, Director
--
--
Ms. Michele M. Larios, J.D.
Ms. Michele M. Larios, J.D.
Vice President, General Counsel, Secretary
Vice President, General Counsel, Secretary
--
--
Mr. Walter O. Bigby, Jr.
Mr. Walter O. Bigby, Jr.
Independent Director
Independent Director
--
--
Ms. Amy Mack
Ms. Amy Mack
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas J. Shaw
Mr. Thomas J. Shaw
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
16.33M
+0.34%
Mr. Marco Laterza, CPA
Mr. Marco Laterza, CPA
Independent Director
Independent Director
85.00K
--
Mr. Darren E. Findley
Mr. Darren E. Findley
Independent Director
Independent Director
4.20K
--
Mr. John W. Fort, III
Mr. John W. Fort, III
Chief Financial Officer, Vice President, Treasurer, Director
Chief Financial Officer, Vice President, Treasurer, Director
--
--
Ms. Michele M. Larios, J.D.
Ms. Michele M. Larios, J.D.
Vice President, General Counsel, Secretary
Vice President, General Counsel, Secretary
--
--
Mr. Walter O. Bigby, Jr.
Mr. Walter O. Bigby, Jr.
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Syringes
6.96M
83.91%
EasyPoint Needles
983.52K
11.86%
Blood Cllection Products
343.83K
4.14%
Other Products
7.68K
0.09%
By RegionUSD
Name
Revenue
Proportion
United States
7.43M
89.60%
North and South America(excluding U.S)
553.50K
6.67%
Other International
309.36K
3.73%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Syringes
6.96M
83.91%
EasyPoint Needles
983.52K
11.86%
Blood Cllection Products
343.83K
4.14%
Other Products
7.68K
0.09%
Shareholding Stats
Updated: Sat, Jul 19
Updated: Sat, Jul 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Shaw (Thomas J)
54.54%
Larios Michele Mitchell
2.88%
The Vanguard Group, Inc.
2.30%
Renaissance Technologies LLC
1.20%
BlackRock Institutional Trust Company, N.A.
0.91%
Other
38.17%
Shareholders
Shareholders
Proportion
Shaw (Thomas J)
54.54%
Larios Michele Mitchell
2.88%
The Vanguard Group, Inc.
2.30%
Renaissance Technologies LLC
1.20%
BlackRock Institutional Trust Company, N.A.
0.91%
Other
38.17%
Shareholder Types
Shareholders
Proportion
Individual Investor
58.00%
Investment Advisor
4.68%
Hedge Fund
1.93%
Investment Advisor/Hedge Fund
0.94%
Venture Capital
0.07%
Research Firm
0.07%
Other
34.31%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
76
19.64M
65.62%
-740.48K
2025Q1
78
19.36M
64.67%
-761.97K
2024Q4
83
19.19M
64.11%
-1.01M
2024Q3
90
19.53M
65.24%
-827.36K
2024Q2
106
19.17M
64.04%
-1.44M
2024Q1
142
19.01M
63.51%
-2.11M
2023Q4
155
19.23M
64.23%
-1.87M
2023Q3
169
20.44M
68.26%
-2.39M
2023Q2
184
20.87M
69.70%
-2.42M
2023Q1
199
21.07M
70.37%
-2.41M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Shaw (Thomas J)
16.27M
54.36%
+59.56K
+0.37%
Jun 30, 2025
Larios Michele Mitchell
861.00K
2.88%
--
--
Mar 10, 2025
The Vanguard Group, Inc.
689.51K
2.3%
--
--
Mar 31, 2025
Renaissance Technologies LLC
359.64K
1.2%
-1.61K
-0.45%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
271.54K
0.91%
-633.00
-0.23%
Mar 31, 2025
Bridgeway Capital Management, LLC
155.63K
0.52%
+10.80K
+7.46%
Mar 31, 2025
Citadel Advisors LLC
152.96K
0.51%
+78.55K
+105.56%
Mar 31, 2025
Geode Capital Management, L.L.C.
128.25K
0.43%
+9.08K
+7.62%
Mar 31, 2025
Axiom Asset Management
101.53K
0.34%
--
--
Mar 31, 2025
Laterza (Marco)
85.00K
0.28%
--
--
Mar 10, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI